LAWRENCE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics Inc. (“ BTI ”) (OTCQB:BTHE), a BioPharmaceutical leader in the design, development and commercialization of innovative therapeutics for sugar management, diabetes and related complications, announces the launch its social commerce distribution channel in China via WeChat, a platform that employs social media to promote online shopping experiences that are “viral, addictive and hyper-social”. The interactive WeChat...